Disposition and metabolism of the antitumor agent pyrazine-2-diazohydroxide in mouse and beagle dog David J. MooreJoanne I. BrodfuehrerGarth Powis Original Articles Pages: 269 - 273
Selectivity of the anthracyclines for negatively charged model membranes: role of the amino group Thomas G. BurkeAlan C. SartorelliThomas R. Tritton Original Articles Pages: 274 - 280
Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity Beverly A. TeicherSamuel D. BernalKathleen N. S. Cathcart Original Articles Pages: 281 - 285
The effect of fluosol-DA and oxygenation status on the activity of cyclophosphamide in vivo Beverly A. TeicherTerence S. HermanKathleen N. S. Cathcart Original Articles Pages: 286 - 291
Development of alkylating agent-resistant human tumor cell lines Beverly A. TeicherEmil Frei III Original Articles Pages: 292 - 298
Liposomes as drug carrier system for cis-diamminedichloroplatinum (II) P. A. SteerenbergG. StormW. H. de Jong Original Articles Pages: 299 - 307
Inhibition of spontaneous and experimental metastasis by a new derivative of camptothecin, CPT-11, in mice Takeshi MatsuzakiTeruo YokokuraTakashi Tsuruo Original Articles Pages: 308 - 312
Effect of methotrexate on homocysteine and other sulfur compounds in tissues of rats fed a normal or a defined, choline-deficient diet Asbjørn Martin SvardalPer Magne UelandHelga Refsum Original Articles Pages: 313 - 318
Cytotoxicity of ketoconazole in malignant cell lines C. F. RochlitzL. E. DamonE. C. Cadman Original Articles Pages: 319 - 322
The influence of ranitidine on the pharmacokinetics and toxicity of doxorubicin in rabbits N. Lindsay HarrisDean E. BrennerKenneth R. Hande Original Articles Pages: 323 - 328
Effect of verapamil on doxorubicin activity and pharmacokinetics in mice bearing resistant and sensitive solid tumors Franca FormelliLoredana ClerisRoberto Carsana Original Articles Pages: 329 - 336
The effects of antibiotics and uricosuric drugs on the renal elimination of methotrexate and 7-hydroxymethotrexate in rabbits Heiko IvenHelmut Brasch Original Articles Pages: 337 - 342
Phase I and pharmacokinetic studies with the pentacyclic pyrroloquinone mitoquidone Paul A. J. SpethMartin E. GoreGrahaem W. Brown Original Articles Pages: 343 - 346
Fatal esorubicin-induced cardiomyopathy: report of a case and review of the literature Louis F. DiehlAlan BanksRaymond B. Weiss Original Articles Pages: 347 - 350
A phase II study of oral idarubicin (4-demethoxydaunorubicin) in advanced breast cancer Nicholas S. A. StuartMichael H. CullenChristopher J. Tyrrell Original Articles Pages: 351 - 354
In response to Vriesendorp et al. Prediction of normal tissue damage by cancer chemotherapy John A. Green Letter to the Editors Pages: 355 - 355
